We have attached herewith the Audited Financial Results (Standalone and Consolidated) together with the Report of the Auditor thereon. Please take the same on your record.
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anlon Healthcare reported strong topline growth with standalone revenue rising 46.7% YoY to Rs 17,650 Lakhs and consolidated revenue up 43% to Rs 17,197 Lakhs. Standalone PAT grew 223% to Rs 1,665 Lakhs, while consolidated PAT jumped 41.8% to Rs 2,909 Lakhs, driven by Apiqo Organics subsidiary. The company issued an unmodified (clean) audit opinion with no qualifications. However, operating cash flow turned sharply negative at Rs -6,661 Lakhs (standalone: Rs -5,610 Lakhs), primarily due to a near-4x surge in trade receivables to Rs 10,417 Lakhs, indicating collection challenges. Borrowings grew significantly (consolidated borrowings ~Rs 9,567 Lakhs), partly from post-IPO expansion. The company listed on NSE/BSE in September 2025.
Revenue and profit growth are impressive, but the sharp deterioration in operating cash flow and soaring receivables signal execution risk and warrant close monitoring — the clean audit provides assurance on reported numbers.